Stay updated with breaking news from Devin Mclaughlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHICAGO — Neoadjuvant FOLFIRINOX chemotherapy failed to extend OS compared with upfront surgery for patients with resectable pancreatic head cancer, according to study results presented at ASCO Annual Meeting.“Neoadjuvant FOLFIRINOX showed acceptable safety and resectability rates,” Knut Jørgen Labori, MD, PhD, of the department of hepato-pancreato-biliary surgery at Oslo
CHICAGO — First-line chemotherapy plus bevacizumab and durvalumab — followed by maintenance durvalumab, bevacizumab and olaparib — extended PFS compared with standard of care for women with non-BRCA-mutated advanced ovarian cancer.The findings of an interim analysis of the three-arm, randomized phase 3 DUO-O trial, presented at ASCO Annual Meeting, also noted a numerical
Norman Merrill II, 46, pleaded guilty in December to one count of possession of child sexual abuse materials, according to court documents. Two remaining counts were dismissed.
The FDA expanded the approval of abemaciclib, combined with endocrine therapy, as adjuvant treatment for adults with hormone receptor-positive, HER2-negative, node-positive early breast cancer. The label expansion removes the Ki-67 score requirement for selection of patients for treatment with abemaciclib (Verzenio, Eli Lilly), a cyclin-dependent kinase (CDK) 4/6 inhibitor. Patients with
Are you interested in exploring abstract painting?